Protein S deficiencyD68.5

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Protein S defect

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Autosomal-dominantly inherited (analogous to protein C deficiency) or acquired disease associated with reduced fibrinolytic activity and an increased risk of thrombosis due to a lack of protein S. In the hereditary form, mutations in the protein S-alpha gene (PROS1 gene) are present. Up to now > 100 different mutations in the PROS1 gene have been described.

ClassificationThis section has been translated automatically.

The protein S deficiency is divided into 3 groups:

  • Type I: The activity and the total and free antigen (concentration) are reduced.
  • Type II: The activity is reduced, free and total antigen are normal.
  • Type III: The activity as well as the free antigen are reduced, the total antigen is normal (C4B binding protein is increased.

Occurrence/EpidemiologyThis section has been translated automatically.

The prevalence in the normal population is approx. 0.03 - 0.13%; in patients with thrombophilia (increased tendency to thrombosis) it is 5 - 15%.

EtiopathogenesisThis section has been translated automatically.

Protein S is a vitamin K-dependent plasma protein that acts as a cofactor in the activation of protein C. Protein S alone has no influence on a clotting process. Together in complex with Protein C, Protein S accelerates the effect of Protein C due to its extremely high affinity for negatively charged phospholipid surfaces. 60% of the protein S in plasma is bound to the complement binding protein C. 40% circulate in free form. The free and the bound form can be determined separately. Heterozygous deficiencies are detectable in 2-5% of thrombosis patients.

In addition to hereditary deficiency, protein S deficiency can also be caused by exogenous factors:

  • Liver diseases, so that synthetic weakness
  • Waste in acute respiratory distress syndrome (ARDS)
  • Cirrhosis of the liver
  • Coumarin therapy
  • Asparaginase therapy
  • Consumption coagulopathy
  • Sepsis
  • Chronic inflammatory bowel disease
  • Viral infections.

ManifestationThis section has been translated automatically.

Congenital protein S deficiency is an autosomal-dominant inherited disease (analogous to protein C deficiency) that is associated with a significantly increased risk of thrombosis. Mutations in the protein S-alpha gene (PROS1 gene) are present. Up to now > 100 versch. mutations in the PROS1 gene have been described.

Note(s)This section has been translated automatically.

The molecular weight of the protein S is 69,000 D. The plasma concentration of the total protein is 20-25 mg/l or 60-120%. The free protein S is 7-10 mg/l, corresponding to an activity of 23-49 mg/l of the total protein. The half-life is 42.5 hours. Apart from the liver, synthesis takes place in the endothelium and megakaryocytes.

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW Scientific Publisher GmbH Berlin S. 220f

Authors

Last updated on: 29.10.2020